文献速递脊柱关节炎

银屑病关节炎筛查工具的系统综述与荟萃分析

Psoriatic arthritis screening: a systematic review and meta-analysis.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

该研究系统综述了用于银屑病患者银屑病关节炎(PsA)筛查的问卷工具准确性,纳入42篇文献进行定性合成、27篇进行定量合成。荟萃分析显示早期银屑病关节炎筛查问卷(EARP)的敏感性和特异性均为0.85,表现略优于其他工具;问卷类工具总体具有中等准确性。

要点

  • 问卷类PsA筛查工具在银屑病患者中具有中等准确性。
  • EARP的敏感性和特异性均为0.85,略优于ToPAS、PEST和PASE。
  • 年龄、患者选择偏倚风险和筛查工具可解释部分异质性。

核心结论

  • 问卷类工具在银屑病患者中识别PsA具有中等准确性。
  • EARP的准确性似乎略优于ToPAS、PEST和PASE。

研究设计与样本

  • 系统综述检索MEDLINE、EMBASE、CENTRAL和Web of Science,评价自我填写的PsA筛查工具在银屑病患者中的准确性。
  • 共识别2280条参考文献,130篇全文评估,42篇纳入合成,其中27篇纳入定量合成。
  • 采用双变量荟萃分析合并工具特异性敏感性和特异性,并用meta回归评估诊断比值比异质性。

主要发现

  • 37%的记录总体偏倚风险低。
  • EARP报告了最高的敏感性和特异性,均为0.85。
  • 诊断比值比的I²在76%至90.1%之间。
  • Meta回归显示年龄、患者选择偏倚风险和筛查工具可解释部分异质性。

关键数值与推荐

  • PASE(切点=44)、PASE(切点=47)、ToPAS(切点=8)、PEST(切点=3)和EARP(切点=3)的合并敏感性和特异性已计算。
  • EARP的敏感性和特异性均为0.85。

临床怎么用

  • 问卷类工具可用于银屑病患者中PsA的筛查,但准确性中等,需结合临床判断。
  • EARP可能略优于其他问卷工具,但需考虑异质性。

局限性

  • 诊断比值比存在显著异质性(I² 76–90.1%)。
  • 仅37%的记录总体偏倚风险低。
  • 需经济评价来模拟不确定性和估计筛查项目的成本效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To systematically review the accuracy and characteristics of different questionnaire-based PsA screening tools. METHODS: A systematic review of MEDLINE, Excerpta Medical Database, Cochrane Central Register of Controlled Trials and Web of Science was conducted to identify studies that evaluated the accuracy of self-administered PsA screening tools for patients with psoriasis. A bivariate meta-analysis was used to pool screening tool-specific accuracy estimates (sensitivity and specificity). Heterogeneity of the diagnostic odds ratio was evaluated through meta-regression. All full-text records were assessed for risk of bias with the QUADAS 2 tool. RESULTS: A total of 2280 references were identified and 130 records were assessed for full-text review, of which 42 were included for synthesis. Of these, 27 were included in quantitative syntheses. Of the records, 37% had an overall low risk of bias. Fourteen different screening tools and 104 separate accuracy estimates were identified. Pooled sensitivity and specificity estimates were calculated for the Psoriatic Arthritis Screening and Evaluation (cut-off = 44), Psoriatic Arthritis Screening and Evaluation (47), Toronto Psoriatic Arthritis Screening (8), Psoriasis Epidemiology Screening Tool (3) and Early Psoriatic Arthritis Screening Questionnaire (3). The Early Psoriatic Arthritis Screening Questionnaire reported the highest sensitivity and specificity (0.85 each). The I2 for the diagnostic odds ratios varied between 76 and 90.1%. Meta-regressions were conducted, in which the age, risk of bias for patient selection and the screening tool accounted for some of the observed heterogeneity. CONCLUSIONS: Questionnaire-based tools have moderate accuracy to identify PsA among psoriasis patients. The Early Psoriatic Arthritis Screening Questionnaire appears to have slightly better accuracy compared with the Toronto Psoriatic Arthritis Screening, Psoriasis Epidemiology Screening Tool and Psoriatic Arthritis Screening and Evaluation. An economic evaluation could model the uncertainty and estimate the cost-effectiveness of PsA screening programs that use different tools.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Iragorri N, Hazlewood G, Manns B, et al. Psoriatic arthritis screening: a systematic review and meta-analysis. Rheumatology (Oxford). 2019. PMID: 30380111. doi:10.1093/rheumatology/key314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。